Babraham Institute subsidiary companies

The Babraham Institute is committed to promoting the translation of research via national and international collaborations with academics, clinicians and industry. A distinct organisation, Babraham Institute Enterprises Ltd. (BIE), exists to support the delivery of commercialisation of the Institute’s science through managing the Institute’s intellectual property, facilitating interactions between Institute researchers and industry, and arranging access to the Institute’s scientific expertise and facilities. BIE income in 2018/19 was over £1.4M. BIE and the Institute currently work with over 67 industry partners including both large pharmaceutical companies and smaller and medium sized biotechs, many of which are located on the Babraham Research Campus (BRC).

Babraham Institute is located within the BRC alongside over 65 commercial companies. The campus has flourished since being established as a bioincubator model founded by the Institute in 1998 and has received significant investment from the BBSRC over the course of its development. Recognised as a worldleading bioincubator site, the campus is now managed and developed by Babraham Bioscience Technologies Ltd. (BBT) and promotes innovation across the academic and commercial sectors. BBT is the majority owned (75%) subsidiary company of the Institute while the BBSRC is the landlord and 25% shareholder. The campus provides bespoke accommodation for bioventures at any stage in the business development cycle and supports the full spectrum of science from R&D to commercial realisation. The Institute operates an active programme of knowledge exchange with a particular focus on developing relationships with campus companies.

Babraham Institute Enterprise